The primary objective of the study was to demonstrate Zepbound's superiority in percentage change from baseline in body weight at 72 weeks compared to Wegovy
GLP-1 is specifically designed for individuals with a BMI greater than 30 or a BMI greater than 27 with at least one cardiometabolic risk factor, such as high blood pressure, high cholesterol, pre-diabetes, or type 2 diabetes
The patient reported taking blood pressure medications in the morning and admitted to sub-optimal adherence with his recommended continuous positive airway pressure (CPAP) device
Ozempic is intended for long-term use in managing type 2 diabetes
Explore your options and check your eligibility for Mochi Healths weight loss program today
It is not easily worn when placed in daily use, and can effectively protect the pen body and accessories from collisions, dust and water stains when traveling